872682-62-7 Usage
Molecular structure
The compound is a derivative of pyrazolo[3,4-b]pyridine, which is a heterocyclic compound containing a pyridine ring and a pyrazole ring fused together.
Chlorophenyl group
The presence of a 3-chlorophenyl group in the structure suggests potential interactions with biological targets and contributes to the compound's pharmacological properties.
Ethyl ester group
The ethyl ester group attached to the carboxylic acid function indicates that the compound may be converted into its corresponding acid or amide form for further biological evaluation.
Potential pharmaceutical applications
Due to its unique structural features and heterocyclic nature, the compound may be used in medicinal chemistry research for the development of novel drugs for various therapeutic purposes.
Biological activities
As a derivative of pyrazolo[3,4-b]pyridine, the compound may exhibit diverse biological activities, which could be further explored and utilized in drug development.
Hydrogen bonding
The presence of the pyridine and pyrazole rings, as well as the carboxylic acid function, may allow the compound to form hydrogen bonds with biological targets, influencing its binding affinity and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 872682-62-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,2,6,8 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 872682-62:
(8*8)+(7*7)+(6*2)+(5*6)+(4*8)+(3*2)+(2*6)+(1*2)=207
207 % 10 = 7
So 872682-62-7 is a valid CAS Registry Number.
872682-62-7Relevant academic research and scientific papers
Pyrazolopyridine derivatives
-
Page/Page column 9, (2010/02/15)
The invention relates to compound of the formula (I) or its salt, in which R1, R2, R3 and R4 are as defined in the description, their use of as medicament, the process for their preparation and use for the treatment of PDE-IV or TNF-α mediated diseases.
